Investigators recently inspected the company’s facility and found poor sterile production practices, which resulted in the initial product alert. This week that alert was expanded.
The agency has not learned of any adverse events from improperly sterilized NuVision products. The alert is cautionary.
More Articles on Anesthesia:
FDA Changes Label, Lowers Dose Recommendation for Zolpidem Insomnia Drug
Masimo Announces Clinical Study Outcomes at International Anesthesia Research Society Meeting
Physician Office Partners Releases Billing Solution for Anesthesia Practices
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Legal & Regulatory Issues
-
Joplin, Mo.-based Freeman Health System and Fort Scott, Kan.-based Kansas Renewal Institute have signed a nonbinding letter of intent to…
-
Financial pressure is accelerating consolidation at a pace not seen in years. Staffing shortages, aging infrastructure, heavy Medicaid and Medicare…
-
An Ormond Beach (Fla.) Police Department officer was shot at a Daytona Beach, Fla., hospital Sept. 21 while guarding a…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
